ORGANIC
LETTERS
2011
Vol. 13, No. 21
5842–5845
Gold(I)-Catalyzed Formation of
3-Pyrazolines through Cycloaddition of
Diaziridine to Alkynes
David A. Capretto, Chad Brouwer, Catherine B. Poor, and Chuan He*
Department of Chemistry and Institute for Biophysical Dynamics,
The University of Chicago, 929 East 57th Street, Chicago, Illinois 60637, United States
Received September 9, 2011
ABSTRACT
This work reports the high-yield formation of pyrazoline derivatives mediated by gold(I) catalysts. The reaction utilizes a diaziridine, which has
seen only limited usage in organic methodology. Mechanistic studies suggest a gold-mediated opening of the diazridine ring, alkyne insertion, and
finally an intramolecular hydroamination to furnish the product.
Pyrazolines have been heavily investigated due to their
occurrence in a number of biologically active molecules.
Various pyrazolines have exhibited antibacterial, anti-
amoebic, antitumor, anti-inflammatory, antidepressant,
and MAO-inhibitory activities.1 It is therefore important
to be able to access them through methods that are rapid,
cost-effective, and atom-economical. Pyrazolines are typi-
cally synthesized by the condensation/addition of hydrazines
onto R,β-unsaturated carbonyl compounds.2,3 More re-
cently, azomethine iminies have been used to form pyrazo-
line-containing scaffolds via cycloaddition onto alkynes.4
(4) (a) Shintani, R.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 10778–
ꢀ
10779. (b) Suarez, A.; Downey, C. W.; Fu, G. C. J. Am. Chem. Soc. 2005,
127, 11244–11245. (c) Shapiro, N. D.; Shi, Y.; Toste, F. D. J. Am. Chem.
Soc. 2009, 131, 11654–11655. (d) Oishi, T.; Yoshimura, K.; Yamaguchi,
K.; Mizuno, N. Chem. Lett. 2010, 39, 1086–1087.
(5) Okitsu, T.; Sato, K.; Wada, A. Org. Lett. 2010, 12, 3506–3509.
(6) (a) Rudolph, M.; Hashmi, A. S. K. Chem. Commun. 2011, 47,
6536–6544. (b) Boorman, T. C.; Larrosa, I. Chem. Soc. Rev. 2011, 40,
1910–1925. (c) Driver, T. G. Org. Biomol. Chem. 2010, 8, 3831–3846. (d)
Li, Z.; Brouwer, C.; He, C. Chem. Rev. 2008, 108, 3239–3265. (e)
(1) (a) Sivakumar, P. M.; Seenivasan, S. P.; Kuman, V.; Doble, M.
Bioorg. Med. Chem. Lett. 2010, 20, 3169–3172. (b) Hayat, F.;Salahuddin,
A.; Umar, S.; Azam, A. Eur. J. Med. Chem. 2010, 45, 4669–4675. (c)
Abid, M.; Azam, A. Bioorg. Med. Chem. Lett. 2006, 16, 2812–2816. (d)
Banday, A. H.; Mir, B. P.; Lone, I. H.; Suri, K. A.; Kumar, H. M. S.
Steroids 2010, 75, 805–809. (e) Khode, S.; Maddie, V.; Aragade, P.;
Palkar, M.; Ronad, P. K.; Mamledesai, S.; Thippeswamy, A. H. M.;
Satyanarayana, D. Eur. J. Med. Chem. 2009, 44, 1682–1688. (f) Rathish,
I. G.; Javed, K.; Ahmad, S.; Bano, S.; Alam, M. S.; Pillai, K. K.; Singh,
S.; Bagchi, V. Bioorg. Med. Chem. Lett. 2009, 19, 255–258. (g) Joshi,
R. S.; Mandhane, P. G.; Diwakar, S. D.; Dabhade, S. K.; Gill, C. H.
Bioorg. Med. Chem. Lett. 2010, 20, 3721–3725. (h) Prasad, Y. R.; Rao,
A. L.; Prasoona, L.; Murali, K.; Kumar, P. R. Bioorg. Med. Chem. Lett.
2005, 15, 5030–5034. (i) Karuppasamy, M.; Mahapatra, M.; Yabanoglu,
S.; Ucar, G.; Sinha, B. N.; Basu, A.; Mishra, N.; Sharon, A.; Kulandaivelu,
U.; Jayaprakash, V. Bioorg. Med. Chem. 2010, 18, 1875–1881.
(2) (a) For a background on pyrazoline-type molecules, see: Jarboe,
C. H. The Chemistry of Heterocyclic Compounds; Interscience Publishers:
New York, 1967; Vol. 22, pp 177ꢀ286. (b) For more recent works, see:
Eicher, T.; Hauptmann, S. The Chemistry of Heterocycles; Wiley-VCH:
New York, 2003.
€
Furstner, A.; Davies, P. W. Angew. Chem., Int. Ed. 2007, 46, 3410–
3449. (f) Li, H.; Widenhoefer, R. A. Org. Lett. 2009, 11, 2671–2674. (g)
Yang, C. G.; He, C. J. Am. Chem. Soc. 2005, 127, 6966–6967. (h) Zhang,
J.; Yang, C. G.; He, C. J. Am. Chem. Soc. 2006, 128, 1798–1799. (i)
Wang, Z. J.; Benitez, D.; Tkatchouk, E.; Goddard, W. A., III; Toste,
F. D. J. Am. Chem. Soc. 2010, 132, 13064–13071. (j) Melhado, A. D.;
Brenzovich, W. E.; Lackner, A. D.; Toste, F. D. J. Am. Chem. Soc. 2010,
132, 8885–8887. (k) Peng, Y.; Cui, L.; Zhang, G.; Zhang, L. J. Am.
Chem. Soc. 2009, 131, 5062–5063. (l) Sun, J.; Conley, M. P.; Zhang, L.;
Kozmin, S. A. J. Am. Chem. Soc. 2006, 128, 9705–9710. (m) Zhang, L;
Kozmin, S. A. J. Am. Chem. Soc. 2005, 127, 6962–6963. (n) Hashmi,
A. S. K.; Frost, T. M.; Bats, J. W. J. Am. Chem. Soc. 2000, 122, 11553–
11554. (o) Hashmi, A. S. K.; Rudolph, M.; Bats, J. W.; Frey, W.;
ꢀ
Rominger, F.; Oeser, T. Chem.;Eur. J. 2008, 14, 6672–6678. (p) Lopez-
Carrillo, V.; Echavarren, A. M. J. Am. Chem. Soc. 2010, 132, 9292–9294.
ꢀ
(q) Escribano-Cuesta, A.; Lopez-Carrillo, V.; Janssen, D.; Echavarren,
A. M. Chem.;Eur. J. 2009, 15, 5646–5650. (r) Luo, T.; Schreiber, S. L.
Angew. Chem., Int. Ed. 2007, 46, 8250–8253. (s) Akana, J. A.; Bhattacharyya,
€
K. X.; Muller, P.; Sadighi, J. P. J. Am. Chem. Soc. 2007, 129, 7736–7737.
(3) (a) Alex, K.; Tillack, A.; Schwarz, N.; Beller, M. Org. Lett. 2008,
10, 2377–2379. (b) Cui, S. L.; Wang, J.; Wang, Y. G. Org. Lett. 2008, 10,
13–16.
(t) Marion, N.; Nolan, S. P. Angew. Chem., Int. Ed. 2007, 46, 2750–2752.
(u) Atoniotti, S.; Genin, E.; Michelet, V.; Genet, J.P.J. Am. Chem. Soc. 2005,
127, 9976–9977.
^
r
10.1021/ol202452b
Published on Web 10/11/2011
2011 American Chemical Society